Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Enterprise Value (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted Enterprise Value of $118.0 billion for Q2 2026, up 11.05% on a QoQ basis from $106.2 billion in Q1 2026, and up 9.54% year-over-year from $107.7 billion in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) Enterprise Value (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals has reported Enterprise Value for 18 years, with the latest figure at $118.0 billion in Q2 2026.

  • On a quarterly basis, Enterprise Value rose 9.54% year-over-year to $118.0 billion in Q2 2026; TTM through Jun 2026 was $118.0 billion, a 9.54% increase from a year earlier, with the FY2025 full-year figure at $108.5 billion, up 11.49% from the prior year.
  • Enterprise Value was $118.0 billion for Q2 2026 at Vertex Pharmaceuticals, up from $106.2 billion in the prior quarter.
  • The five-year high for Enterprise Value was $118.4 billion in Q1 2025, with the low at $58.5 billion in Q1 2022.
  • Average Enterprise Value over 5 years is $91.5 billion, with a median of $95.5 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Enterprise Value soared 63.34% in 2022, then decreased 17.8% in 2025.
  • Over 5 years, Enterprise Value stood at $63.4 billion in 2022, then jumped by 47.59% to $93.6 billion in 2023, then gained by 3.97% to $97.4 billion in 2024, then rose by 11.49% to $108.5 billion in 2025, then increased by 8.71% to $118.0 billion in 2026.
  • The last three Enterprise Value figures came in at $118.0 billion (Q2 2026), $106.2 billion (Q1 2026), and $108.5 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.99 Bn
Mar 31, 2026 106.25 Bn
Dec 31, 2025 108.54 Bn
Sep 30, 2025 93.17 Bn
Jun 30, 2025 107.72 Bn
Mar 31, 2025 118.38 Bn
Dec 31, 2024 97.35 Bn
Sep 30, 2024 113.35 Bn
Jun 30, 2024 115.14 Bn
Mar 31, 2024 97.80 Bn
Dec 31, 2023 93.64 Bn
Sep 30, 2023 77.73 Bn
Jun 30, 2023 79.48 Bn
Mar 31, 2023 70.72 Bn
Dec 31, 2022 63.44 Bn
Sep 30, 2022 64.54 Bn
Jun 30, 2022 62.89 Bn
Mar 31, 2022 58.46 Bn
Dec 31, 2021 48.36 Bn
Sep 30, 2021 39.51 Bn
API Access

Vertex Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=VRTX&period=max&api_key=YOUR_API_KEY